Ignite Creation Date:
2024-05-06 @ 8:54 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02855268
Status:
TERMINATED
Last Update Posted:
2023-10-23
First Post:
2016-07-28
Brief Title:
Study of Lademirsen SAR339375 in Patients With Alport Syndrome
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-28
First Submit QC Date:
August 1 2016
Study First Post Date:
2016-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-10-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-19
Last Update Post Date:
2023-10-23
Last Update Post Date Type:
ACTUAL